Why it matters
THC-O is produced by acetylating THC with acetic anhydride. The resulting ester is non-active until the body cleaves the acetyl group, producing a pharmacology described as delayed-onset and high-potency. Some reports characterise THC-O as three times the potency of delta-9 at equivalent dose.
In practice
Practical caution is warranted. The 2022 EVALI-style concern about heated acetates producing ketene gas applies — vape-cart THC-O carries a respiratory risk profile distinct from the parent cannabinoid. Most harm-reduction resources currently advise against vaping THC-O.
Common confusion
THC-O is sometimes treated as a stronger THC. The pharmacology is closer to a sustained-release THC ester than to a more potent THC variant.
This glossary entry is editorial content reviewed against primary sources. It is not medical advice. See our Editorial Policy.
